Evidence map›Paper›PMID 32430714›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2020

Establishment and Characterization of a Stromal Cell Line Derived From a Patient With Thoracic Endometriosis.

J Gogusev, Y Lepelletier, L El Khattabi, M Grigoroiu, P Validire

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. CD73: Friend or Foe in Lung Injury.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J GogusevCochin Institute, Inserm UMR 1016, CNRS 8104, Université Paris Descartes, 24 rue du faubourg St Jacques, 75014, Paris, France. jean.gogusev@gmail.com.
Y LepelletierImagine Institute, Inserm UMR 1163, CNRS ERL 8254, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
L El KhattabiService de Cytogénétique, AP-HP, Hôpital Cochin, Inserm U1016, CNRS 8104, Université Paris Descartes, Paris, France.
M GrigoroiuService de Chirurgie Thoracique, Institut Mutualiste Montsouris, Paris, France.
P ValidireService d'Anatomie Pathologique, Institut Mutualiste Montsouris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thoracic endometriosis (TE) syndrome is a clinical condition known as an extrapelvic form of endometriosis with the presence of functioning endometrial tissue involving lung parenchyma, pleura, chest wall, or diaphragm. In an effort to obtain an endometriosis ex vivo model, we established the spontaneously growing TH-EM1 cell line from endometriotic implants in lung parenchyma from a woman with TE. Maintained in long-term culture, the cells grew as large mesenchymal-like cells with a doubling time between 5 and 6 days. Treatment with medroxyprogesterone acetate (10

Indexed as

AdultCell Culture TechniquesCell ProliferationDiaphragmEndometriosisEndometriumFemaleHumansStromal CellsThoracic Diseasescell linekaryotypemicroarray chromosome analysis (MCA)thoracic endometriosis (TE) syndrome

Identifiers

PMID32430714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.